These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 14981885)

  • 41. Telemedicine: a new paradigm.
    Denton I
    Healthc Inform; 1993 Nov; 10(11):44-6, 48, 50. PubMed ID: 10130474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics.
    Retèl VP; Bueno-de-Mesquita JM; Hummel MJ; van de Vijver MJ; Douma KF; Karsenberg K; van Dam FS; van Krimpen C; Bellot FE; Roumen RM; Linn SC; van Harten WH
    Int J Technol Assess Health Care; 2009 Jan; 25(1):73-83. PubMed ID: 19126254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diffusion of medical technology: medical devices in India.
    Mahal A; Karan AK
    Expert Rev Med Devices; 2009 Mar; 6(2):197-205. PubMed ID: 19298166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New trends in technology assessment: will comparative-effectiveness research and healthcare reform stifle medical device innovation?
    Gross L
    J Ambul Care Manage; 2010; 33(4):350-6. PubMed ID: 20838114
    [No Abstract]   [Full Text] [Related]  

  • 45. International diffusion of new health technologies: a ten-country analysis of six health technologies.
    Packer C; Simpson S; Stevens A;
    Int J Technol Assess Health Care; 2006; 22(4):419-28. PubMed ID: 16984674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Packaging challenges: the solution is just beyond the border.
    Merritt J
    Med Device Technol; 2003 Mar; 14(2):12-5. PubMed ID: 12698691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New and dis-improved: on the evaluation and use of less effective, less expensive medical interventions.
    Kent DM; Fendrick AM; Langa KM
    Med Decis Making; 2004; 24(3):281-6. PubMed ID: 15155017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Medical technology innovation: why get involved and how?].
    Azagury DE; Buchs NC; Volonté F; Morel P
    Rev Med Suisse; 2013 Jun; 9(391):1323-6. PubMed ID: 23875262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disruptive technology: new medical advances are troublesome for even the most successful health systems and innovator health companies.
    Michaelis L; Vaul J; Chumer K; Faul M; Sheehan L; DeCerce J
    J Cardiovasc Manag; 2004; 15(2):9-12. PubMed ID: 15185624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Describing the influence of technologies on registered nurses' work.
    Zuzelo PR; Gettis C; Hansell AW; Thomas L
    Clin Nurse Spec; 2008; 22(3):132-40; quiz 141-2. PubMed ID: 18438162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The critical path to medical innovation.
    Williams D
    Med Device Technol; 2004 Jun; 15(5):8-10. PubMed ID: 15285478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fueling innovation in medical devices (and beyond): venture capital in health care.
    Ackerly DC; Valverde AM; Diener LW; Dossary KL; Schulman KA
    Health Aff (Millwood); 2009; 28(1):w68-75. PubMed ID: 19049999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plotting a strategy. Piecemeal adoption of new technologies can be an expensive mistake.
    Lemer J
    Mod Healthc; 2011 Jul; Suppl():54. PubMed ID: 21938792
    [No Abstract]   [Full Text] [Related]  

  • 54. New medical technologies: lessons from the international experience.
    Doyle Y
    Ir Med J; 1997 Mar; 90(2):50-1. PubMed ID: 9105122
    [No Abstract]   [Full Text] [Related]  

  • 55. Technology assessment: approach and reimbursement.
    Yaszemski MJ; Polly DW; Boden SD; Andersson GB
    Spine (Phila Pa 1976); 2007 May; 32(11 Suppl):S39-43. PubMed ID: 17495585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach.
    Vallejo-Torres L; Steuten LM; Buxton MJ; Girling AJ; Lilford RJ; Young T
    Int J Technol Assess Health Care; 2008; 24(4):459-64. PubMed ID: 18828941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Making the right long-term prescription for medical equipment financing.
    Conbeer GP
    Healthc Financ Manage; 2007 Jun; 61(6):88-93. PubMed ID: 17571713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conditionally funded field evaluations and practical trial design within a health technology assessment framework.
    Bowen JM; Patterson LL; O'Reilly D; Hopkins RB; Blackhouse G; Burke N; Xie F; Tarride JE; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):324-31. PubMed ID: 19394573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Views on health care technology: Americans consider the risks and sources of information.
    Schur CL; Berk ML
    Health Aff (Millwood); 2008; 27(6):1654-64. PubMed ID: 18997224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The emergence of radically new health care technologies: inventive users as innovation networkers.
    Lettl C
    Technol Health Care; 2005; 13(3):169-83. PubMed ID: 15990420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.